Extendicare Stock Performance
| EXE Stock | CAD 10.62 0.04 0.38% |
On a scale of 0 to 100, Extendicare holds a performance score of 15. The firm shows a Beta (market volatility) of -0.19, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Extendicare are expected to decrease at a much lower rate. During the bear market, Extendicare is likely to outperform the market. Please check Extendicare's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Extendicare displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0506 | Payout Ratio 0.2387 | Last Split Factor 43:40 | Forward Dividend Rate 0.48 | Dividend Date 2024-12-16 |
1 | Extendicare Hits New 1-Year High at 9.48 - MarketBeat | 09/18/2024 |
2 | Extendicare Hits New 1-Year High at 9.52 - MarketBeat | 10/01/2024 |
3 | Extendicare FY2024 EPS Estimate Lifted by Leede Financial - MarketBeat | 11/15/2024 |
4 | Shareholders Can Be Confident That Extendicares Earnings Are High Quality - Simply Wall St | 11/19/2024 |
| Begin Period Cash Flow | 167.3 M |
Extendicare |
Extendicare Relative Risk vs. Return Landscape
If you would invest 880.00 in Extendicare on September 1, 2024 and sell it today you would earn a total of 182.00 from holding Extendicare or generate 20.68% return on investment over 90 days. Extendicare is generating 0.3102% of daily returns assuming 1.5284% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Extendicare, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Extendicare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Extendicare, and traders can use it to determine the average amount a Extendicare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EXE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.53 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Extendicare is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Extendicare by adding it to a well-diversified portfolio.
Extendicare Fundamentals Growth
Extendicare Stock prices reflect investors' perceptions of the future prospects and financial health of Extendicare, and Extendicare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Extendicare Stock performance.
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.0716 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.05 B | ||||
| Shares Outstanding | 83.47 M | ||||
| Price To Earning | 26.74 X | ||||
| Price To Book | 7.80 X | ||||
| Price To Sales | 0.64 X | ||||
| Revenue | 1.3 B | ||||
| Gross Profit | 108.53 M | ||||
| EBITDA | 98.61 M | ||||
| Net Income | 33.98 M | ||||
| Cash And Equivalents | 167.28 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 334.52 M | ||||
| Debt To Equity | 6.07 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | 23.28 M | ||||
| Earnings Per Share | 0.73 X | ||||
| Market Capitalization | 886.42 M | ||||
| Total Asset | 672.73 M | ||||
| Retained Earnings | (393.47 M) | ||||
| Working Capital | (39.25 M) | ||||
| Current Asset | 211.37 M | ||||
| Current Liabilities | 218.02 M | ||||
About Extendicare Performance
By examining Extendicare's fundamental ratios, stakeholders can obtain critical insights into Extendicare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Extendicare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.99 | 0.94 | |
| Return On Tangible Assets | 0.06 | 0.07 | |
| Return On Capital Employed | 0.25 | 0.26 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.39 | 0.30 |
Things to note about Extendicare performance evaluation
Checking the ongoing alerts about Extendicare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Extendicare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 14.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Shareholders Can Be Confident That Extendicares Earnings Are High Quality - Simply Wall St |
- Analyzing Extendicare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Extendicare's stock is overvalued or undervalued compared to its peers.
- Examining Extendicare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Extendicare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Extendicare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Extendicare's stock. These opinions can provide insight into Extendicare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.